Tradestie Institutional Equity Comparison Engine

BMRA vs RCEL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

RCEL Overall Edge

RCEL Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Avita Medical, Inc. Common Stock (RCEL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BMRA trades at N/M Forward P/E with -125.2% operating margin (-8.3% YoY revenue) versus RCEL at 10.3x Forward P/E and -33.9% operating margin (+53.1% YoY). In options structure, BMRA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against RCEL sits in SURGE (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner RCEL
BMRA N/M vs RCEL 10.3x Fwd P/E
Growth & Margin Winner RCEL
Op Margin -125.2% vs -33.9% ยท YoY -8.3% vs +53.1%
Momentum & Technical Winner RCEL
1Y -45.6% vs +312.6% ยท 52W Pos 5% vs 80%
Options & Structure Winner RCEL
UNCLASSIFIED (N/A IV) vs SURGE (5th %ile IV)
BMRA NASDAQ
Biomerica Inc
In Vitro & In Vivo Diagnostic Substances
$1.36
+0.0% 1D
Market Cap $6.0M
1M Return -26.49%
1Y Return -45.6%
Forward P/E N/M
Unified AI Score
44.5 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 50.0 Mom 44.0
RCEL NASDAQ
Avita Medical, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$15.43
-1.28% 1D
Market Cap $509.0M
1M Return +18.33%
1Y Return +312.57%
Forward P/E 10.3x
Unified AI Score
53.1 / 100 HOLD
Tech 40.0 Fund 50.0 Flow 71.0 Mom 46.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BMRA -45.6% RCEL +312.57% Spread: +358.17 pp (RCEL Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period BMRA Revenue RCEL Revenue BMRA Op. Margin RCEL Op. Margin Margin Edge
FY2019 $10M $10M -46.4% -466.4% BMRA
FY2020 $10M $10M -41.0% -299.2% BMRA
FY2021 $10M $30M -104.2% -90.8% RCEL
FY2022 $20M $30M -24.0% -79.9% BMRA
FY2023 $10M $50M -135.3% -85.1% RCEL
FY2024 $10M $60M -117.6% -88.1% RCEL
FY2025 $10M $70M -96.7% -59.4% RCEL
FY2026 $0M N/A -119.5% N/A BMRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BMRA (2) vs RCEL (8)
Institutional Metric BMRA RCEL Criterion Row Winner
Market Capitalization Scale $6.0M $509.0M Larger Scale RCEL
Trailing P/E Ratio Valuation N/M 10.3x Lower Multiple RCEL
Forward P/E Ratio Valuation N/M 10.3x Lower Multiple RCEL
Revenue Growth (YoY) Growth -8.3% +53.1% Higher Growth RCEL
Operating Margin (TTM) Profitability -125.2% -33.9% Higher Margin RCEL
Net Profit Margin Profitability -115.5% -42.6% Higher Margin RCEL
Return on Equity (ROE) Capital Efficiency -113.8% -1746.3% Higher ROE BMRA
52-Week Range Position Momentum 5% ($1โ€“$3) 80% ($3โ€“$18) Stronger Trend RCEL
Beta / 30D Volatility Risk Regime 0.67ฮฒ ยท 62% Vol 1.70ฮฒ ยท 72% Vol Lower Realized Risk BMRA
Unified Institutional Score Composite Signal 44.5 / 100 (HOLD) 53.1 / 100 (HOLD) Higher Composite RCEL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BMRA vs RCEL Buy Guide
BMRA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BMRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
RCEL SURGE
13d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live RCEL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BMRA nor RCEL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.